The goal of this study was to investigate changes in glutamatergic syn
apses in the striatum of rats at two different time-points following a
unilateral injection of 6-hydroxydopamine into the medial forebrain b
undle. One month following this lesion of the nigrostriatal pathway, t
here was an increase (70%) in the mean percentage of asymmetrical syna
pses within the dorsolateral striatum containing a discontinuous, or p
erforated, postsynaptic density, possibly suggesting an increase in gl
utamatergic activity. This was correlated, in the same brain region, w
ith a decrease (44%) in the density of glutamate immunoreactivity with
in nerve terminals associated with all asymmetrical synapses and also
with those terminals associated with a perforated postsynaptic density
. These morphological changes were consistent with an increase (>two-f
old) in the basal extracellular level of striatal glutamate, as measur
ed by in vivo microdialysis. The density of GABA immunolabeling within
symmetrical nerve terminals was increased (25%) at this one month tim
e-period. Dopamine levels within the lesioned striatum were >99% deple
ted. However, at three months, while an increase in the mean percentag
e of striatal perforated synapses was maintained, a significant increa
se (50%) in the density of striatal nerve terminal glutamate immunolab
eling within all asymmetrical synapses and those associated with a per
forated postsynaptic density was observed. This was correlated with a
small, but significant, decrease (32%) in the basal extracellular leve
l of striatal glutamate. The density of GABA immunolabeling within ner
ve terminals associated with a symmetrical contact remained elevated a
t this three month time-period, while striatal dopamine levels remaine
d depleted. While the density of nerve terminal GABA immunolabeling re
mained elevated at both the one and three month time-periods, there ap
peared to be a differential effect on glutamatergic synapses. The in v
ivo microdialysis data suggest that glutamate synapses were more activ
e at a basal level at one month and become less active compared to the
control group at the three month time-period. These data suggest that
there are compensatory changes in glutamatergic synapses within the s
triatum following a 6-hydroxydopamine lesion that appear to be indepen
dent of the level of striatal dopamine or GABA. We propose that change
s in the activity of the thalamo-cortico-striatal pathway may help to
explain the differential time-course change in striatal glutamatergic
synaptic activity. (C) 1998 IBRO. Published by Elsevier Science Ltd.